Latest news
Ceruvia Secures $8 Million to Fund Integrated Phase 1/2 Trial of Non-Hallucinogenic LSD Analog for Cluster Headache - TipRanksTipRanks · Mon, 03 Aug 2026 16:51:23 GMTCeruvia Raises $8 Million to Advance Phase 1/2 Trial of Cluster Headache Therapy - citybizcitybiz · Mon, 03 Aug 2026 14:35:45 GMTCeruvia Raises $8 Million to Complete Integrated Phase 1/2 Trial of Proprietary Non-Hallucinogenic LSD Analog for Cluster Headache - PR NewswirePR Newswire · Mon, 03 Aug 2026 14:00:00 GMT